Ticks' evasion cocktail
On page 2019, Déruaz et al. find that ticks might prefer to take on immune cells one at a time rather than brave the whole lot at once.
Some worms and viruses fend off immune cells by neutralizing the chemokines that attract them. These species make one chemokine-blocking protein that covers all the bases. But ticks don't use this one-for-all strategy, the authors now find. Instead, they made at least three singlechemokine blockers, which probably prevent host immune cells from swarming into the bite site and clogging up the ticks' food pipeline. These anti-chemokines, called evasins, each had a unique shape that might contribute to their selectivity.
Ticks might have evolved this selectivity to counter the host's step-wise immune response to the Lyme disease parasite they carry. In parasite-infected hosts, neutrophils usually arrive first to the bite site, followed by eosinophils and monocytes, and finally other immune cells. Tick saliva has different anti-chemokine activity at different times during feeding, suggesting that having several evasins might somehow better counter this staggered cell influx. Viruses, on the other hand, do not have the luxury of combating one cell type at a time and might therefore depend on a single multi-purpose protein.
Spreading tolerance by converting
Unlike some religious leaders, suppressive T cells need more than just charisma to spread messages of tolerance: the cells rely on a cell surface cytokine complex to convert others, according to Andersson et al. (page 1975) .
Regulatory T (T reg) cells suppress other T cells in part via the cytokine TGF-β, which can convert naïve CD4 + T cells into suppressor cells. Andersson et al. now find that naïve CD4 + T cells turn into suppressor cells only when they bump into T reg cells that have an inactive TGF-β complex on their surface. Proteolysis of the inactive complex, which liberates soluble protein, was required for conversion. Inhibiting the protease or swamping the cells with inactive complex prevented cleavage and thus conversion. The converted cells could suppress gut inflammation when transferred into mice suffering from colitis.
Other immune cells also secrete soluble TGF-β, but they do not seem to force conversion-at least in this system. Previous experiments showed that naïve T cells cultured with T reg cell-depleted spleen cells, which secrete TGFβ, fail to convert. Non-T reg cells don't express the inactive surface complex, so perhaps its cleavage is needed to trigger other conversion-supporting signals.
The latent TGF-β complex was present only on T reg cells that had been stimulated via their T cell receptors. This specificity might allow T reg cells to limit conversion by delivering the TGF-β signal only to T cells bound to the same antigen-presenting cell and thus on the verge of being activated. "We wouldn't want T reg cells to run amok and convert all naïve T cells," says lead author Ethan Shevach. How often T reg cells rely on this mechanism and its impact on the induction of tolerance in vivo are unknown.
Naïve-turned-suppressor cells dampen colitis (left).
The arginine-destroying enzyme arginase is elevated in the livers of patients with chronic hepatitis B virus infections.
Ticks secrete several different evasins, each of which blocks a different chemokine.
